Identification of immunogenic epitopes of GAD 65 presented by A(g7) in non-obese diabetic mice

Identification of immunogenic epitopes of GAD 65 presented by A(g7) in non-obese diabetic mice
复制标题

DOI:
10.1007/s002510050238
复制
发表时间:
1997-01-01
期刊:
影响因子:
3.2
通讯作者:
McDevitt, HO
McDevitt, HO
中科院分区:
医学4区
文献类型:
--
作者:
Chao, CC;McDevitt, HO

文献摘要

被引文献

相似文献

自身抗原谷氨酸脱羧酶65 (GAD 65)被认为是胰岛素依赖型糖尿病(IDDM)的重要靶抗原,因为观察到年龄相关的自发耐受性破坏,并且在人类和NOD小鼠中已经报道了细胞介导和自身抗体免疫反应。我们试图鉴定GAD 65的免疫原性表位,它是由I型糖尿病易感等位基因(A(g7))呈递给T细胞的,使用重叠的15-mer合成肽跨越该蛋白的整个序列。通过筛选GAD 65免疫NOD小鼠产生的t细胞杂交瘤,鉴定出4个表位(p206-220, p221-235, p286-300, p571-585)。这些免疫原性表位与先前在NOD小鼠中报道的GAD 65的t细胞表位无关。在gad65氨基酸序列中,206-220和221-235是本研究中发现的两个最主要的t细胞表位。应答GAD 65的T细胞杂交瘤分别有63%和25%对p206-220和p221-235有反应。其余两种多肽(p286-300, p571-585)在t细胞应答中较少占主导地位。GAD 65a (g7)表位全谱的鉴定将进一步研究该自身抗原在IDDM发病机制中的作用。
The autoantigen glutamic acid decarboxylase 65 (GAD 65) is believed to be an important target antigen in insulin-dependent diabetes mellitus (IDDM), since an age-related spontaneous breakdown in tolerance is observed, and cell-mediated and autoantibody immune responses have been reported in humans and NOD mice. We sought to identify immunogenic epitopes of GAD 65 which are presented to T cells by the type I diabetes susceptibility allele (A(g7)), using overlapping 15-mer synthetic peptides spanning the entire sequence of this protein. Four epitopes (p206-220, p221-235, p286-300, p571-585) were identified by screening a panel of T-cell hybridomas generated from GAD 65-immunized NOD mice. These immunogenic epitopes are unrelated to the previously described T-cell epitopes of GAD 65 reported in NOD mice. Of the GAD 65 amino acid sequence, 206-220 and 221-235 are the two most dominant T-cell epitopes identified in this study. Sixty-three percent and 25% of GAD 65-responding T cell hybridomas react to p206-220 and p221-235, respectively. The remaining two peptides (p286-300, p571-585) are less dominant T-cell responses. The identification of the whole spectrum of GAD 65 A(g7) epitopes should further the investigation of the role of this autoantigen in the pathogenesis of IDDM.